Clinilabs
Clinilabs is a privately-held, full-service CRO founded in 2000 that exclusively manages central nervous system (CNS) drug, device, and technology clinical trials from Phase 1 through Phase 4. It serves top global pharmaceutical companies, biotechnology firms, and MedTech developers across psychiatry, neurology, substance use, and rare CNS disorders.
- Company typePrivate
- Founded2000
- HeadquartersNew York, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Clinilabs does
Clinilabs is a privately-held, full-service contract research organization (CRO) founded in 2000 by Dr. Gary Zammit and headquartered in Eatontown, New Jersey. The company is purpose-built for central nervous system (CNS) drug, device, and technology development, serving as the only full-service CRO exclusively focused on neurotherapeutics across psychiatry, neurology, substance use disorders, and rare CNS conditions. Clinilabs reports 25+ years of CNS-specific experience, 800+ completed clinical trials, and contributions to 30+ marketed products across 25+ indications, with 17 of the top 20 global pharmaceutical companies among its clients.
The company's product portfolio spans the full clinical development lifecycle. Core services include Early Phase Development (Phase 1 SAD/MAD, PK/PD, drug-drug interaction studies) executed at two owned Phase 1 clinical research units (100 beds total across Eatontown, NJ and Midtown Manhattan), Phase 2–4 Trial Management for global multicenter studies, and centralized Corelab data services (PSG, EEG, qEEG, ECG, actigraphy, EMG, video ratings) operating from seven laboratories worldwide. Underlying technology is anchored by Clinical InSite™, a proprietary electronic data and document management platform with validated audit trails, remote monitoring, and permission-based file sharing; Clinical InSite 2.0 extends the platform to ingest wearable and medical device data streams via API. Supporting offerings include the Accelerator Sites™ program for accelerated study startup, Placebo Response Management services, Advisory & Regulatory Support (FDA/EMA), and MedTech Clinical Services for 510(k)/PMA pathways.
Clinilabs generates revenue through professional-services, project-based CRO fees structured around trial scope, phase, complexity, and duration. The go-to-market is enterprise-direct, targeting pharmaceutical, biotechnology, and medical device companies through RFP submissions, a dedicated business development team, scientific advisory board credibility, and 15+ annual CNS industry conferences (AAIC, ECNP, FENS, CTAD, CNS Summit, BIO-Europe). Global delivery is supported by owned infrastructure in the US, regional offices in Paris, Basel (EU HQ established Feb 2026), Beijing, and Tokyo, and an investigator network spanning 42 countries. The company is GDPR-compliant, completed a 2026 FDA inspection with no findings, and received a 2025 growth investment from InTandem Capital Partners.
Clinilabs firmographics
Firmographics- Name
- Clinilabs
- Legal name
- Clinilabs
- Website
- https://clinilabs.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Clinilabs is a privately-held, full-service CRO founded in 2000 that exclusively manages central nervous system (CNS) drug, device, and technology clinical trials from Phase 1 through Phase 4. It serves top global pharmaceutical companies, biotechnology firms, and MedTech developers across psychiatry, neurology, substance use, and rare CNS disorders.
- Ownership category
- akta.pro rank
Clinilabs industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Clinilabs is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Clinilabs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Organization Services: Clinilabs generates revenue through full-service contract research organization (CRO) fees for managing CNS drug, device, and technology clinical trials. Services span Phase 1-4 trial management, including early phase development, clinical research unit operations, corelab services, and regulatory advisory. Revenue is project-based with fees structured around scope, duration, and complexity of trials.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Clinilabs product offering
Product offeringCore offering
Clinilabs is a full-service Contract Research Organization (CRO) exclusively focused on clinical development services for central nervous system (CNS) drugs, devices, and technologies. The company manages Phase 1 through Phase 4 trials, operating two Phase 1 clinical research units (100 beds total), a centralized Corelab for PSG/EEG data processing, and a proprietary Clinical InSite data management platform. Service offerings include early phase development, Phase 2-4 trial management, centralized corelab data services, advisory and regulatory support, MedTech clinical trials, the Accelerator Sites program, and placebo response management.
Product overview
Clinilabs is a full-service CNS CRO offering integrated, end-to-end neurotherapeutic clinical trial services across the drug development lifecycle. The portfolio comprises Early Phase Development (Phase 1) and Phase 2-4 Trial Management as the core clinical services, supported by two Physical Clinical Research Units (100 beds across NJ and NYC), the centralized Corelab data services, and a proprietary Clinical InSite technology platform. The Accelerator Sites program and Placebo Response Management service are specialty offerings that enhance site selection and trial quality. Advisory & Regulatory Support and MedTech Clinical Services extend the portfolio to device development. All services are unified under a single CNS therapeutic focus, with the Clinical InSite platform serving as the central data management layer connecting eCRF systems (Medidata RAVE, Medrio), Veeva Vault, and wearable/device data streams.
Differentiator
Problem solved
Functional benefit
Products and services
- Early Phase Development
Quantifiable outcome
- Top-line results delivered just 7 days after database lock for Alzheimer's disease trial
- +4 more outcomes
Companies that use Clinilabs
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Clinilabs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature4 records
Clinilabs partnerships and signals
Strategic signalScale indicators8 records
Recent moves6 records
Expansion highlights5 records
Clinilabs competitors and assessment
Company assessmentDirect peers
- Worldwide Clinical Trials: Mid-sized, scientifically focused CRO with strong CNS, neuroscience, and rare disease expertise. Closest direct competitor to Clinilabs in therapeutic-area specialty CRO positioning, with comparable global trial management and central lab offerings.
- Premier Research: Specialty CRO with deep CNS, neuroscience, and rare disease therapeutic-area focus, plus pediatrics and oncology. Competes head-to-head with Clinilabs for biotech and mid-pharma CNS trial work.
- Medpace: Mid-tier full-service CRO with strong CNS/neurology, metabolic, and oncology franchises. Competes with Clinilabs for Phase 2-4 trial outsourcing from biotech and pharma sponsors, with comparable sponsor relationships.
Broad incumbents
- IQVIA: Largest global CRO with broad therapeutic-area coverage including dedicated CNS and neuroscience teams. Competes for the same RFPs but typically on global scale and integrated technology rather than CNS therapeutic specialization.
- Parexel International: Large global full-service CRO with neuroscience and CNS therapeutic expertise as part of broader portfolio. Competes with Clinilabs particularly for late-stage CNS trials from top pharmaceutical sponsors.
- Syneos Health: Large biopharmaceutical solutions organization combining CRO and commercial services, with neuroscience capabilities. Competes in CNS trial management alongside broader portfolio offerings.
- Charles River Laboratories: Large CRO/CDMO with preclinical and clinical CNS/neuroscience capabilities. Overlaps with Clinilabs on early-phase CNS studies and provides a comparator for sponsor procurement decisions.
Emerging players
- BioPhase Solutions: Smaller specialty clinical research services provider focused on CNS and rare disease trials. Comparable in therapeutic focus but smaller in scale, geographic reach, and proprietary technology stack.
Regional players
- TFS HealthScience: European-headquartered mid-size CRO with CNS, dermatology, and oncology franchises. Competes with Clinilabs in European CNS trial work and shares overlap in sponsor relationships, especially Nordic and EU biotech.
Others
- Cyclerion Therapeutics: Clinical-stage CNS biopharma company developing neurotherapeutics. Not a direct CRO competitor but a representative CNS sponsor in Clinilabs' target customer set, illustrating the kind of biotech clients Clinilabs serves.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key highlights7 records
Customer concentration
Clinilabs social profiles
Digital presenceClinilabs compliance and trust
Trust signalCompliance1 record
Clinilabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinilabs leadership team
Management profileNumber of profiles
Profiles10 records
Clinilabs subsidiaries and ownership
Company hierarchySubsidiaries1 record
Clinilabs funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinilabs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinilabs
What does Clinilabs do?
Clinilabs is a full-service Contract Research Organization (CRO) exclusively focused on clinical development services for central nervous system (CNS) drugs, devices, and technologies. The company manages Phase 1 through Phase 4 trials, operating two Phase 1 clinical research units (100 beds total), a centralized Corelab for PSG/EEG data processing, and a proprietary Clinical InSite data management platform. Service offerings include early phase development, Phase 2-4 trial management, centralized corelab data services, advisory and regulatory support, MedTech clinical trials, the Accelerator Sites program, and placebo response management.
Is Clinilabs a public or private company?
Clinilabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clinilabs founded?
Clinilabs was founded in 2000. It employs 251 to 500 people.
Where is Clinilabs based?
Clinilabs is headquartered in New York, United States, in the North America region.
How does Clinilabs make money?
One revenue line is on record: contract Research Organization Services.
Who are Clinilabs's main competitors?
Direct peers on record are Worldwide Clinical Trials, Premier Research and Medpace. Broad incumbents are IQVIA, Parexel International, Syneos Health and Charles River Laboratories. BioPhase Solutions is listed as an emerging player. TFS HealthScience is listed as a regional player. Cyclerion Therapeutics is listed as an others.
Does Clinilabs have an API?
No public API is recorded for Clinilabs.
What industry is Clinilabs in?
Clinilabs's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 6215 and its SIC code is 8071.